An fMRI Study of the Effects of Clavulanic Acid on Drug Addiction (NCT03713424)

🧪 Interventions in This Study

• Clavulanic Acid (DRUG)
• Placebo oral capsule (DRUG)

Full eligibility criteria are available on the official NIH protocol. View the criteria ↗

📍 All Participating Trial Locations (1 Sites)

• University of Missouri - Columbia — Columbia, Missouri

📞 Contact the Study Coordinator

Phone: (573) 882-2977

Email: athreyam@health.missouri.edu

Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.

💰 Cost, Insurance & Patient Rights

• 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
• Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
• Voluntary Participation: You may withdraw at any time without affecting your standard medical care.

More studies in Tobacco Use Disorder

• Nicotine Replacement Therapy Prescribing and Lung Cancer Screening in Hospitalized Patients — Charleston, South Carolina
• Abstinence Reinforcement Therapy for Veterans Who Smoke Tobacco and Are Experiencing Homelessness — Durham, North Carolina
• 5-HT2A Agonist Psilocybin in the Treatment of Tobacco Use Disorder — Birmingham, Alabama
• Smoking Cessation Behavioral Treatment Study — Columbia, Missouri
• Beta-Adrenergic Modulation of Drug Cue Reactivity — Tulsa, Oklahoma

Explore by condition: All Tobacco Use Disorder clinical trials

💡 How to Participate

1. Check the checklist above to see if you may qualify.
2. Contact the study coordinator using the phone/email above.
3. Ask about the visit schedule, what is covered at no cost, and any travel support.
4. Confirm with your own doctor before making a decision.